THE COST-EFFECTIVENESS OF ALEMTUZUMAB IN THE MANAGEMENT OF RELAPSE-REMITTING MULTIPLE SCLEROSIS IN ITALY

Authors
Category Systematic review
JournalValue in Health
Year 2018
This article has no abstract
Epistemonikos ID: 85335f57cb98f7a53f30ee2599edb1c80e90bca2
First added on: Feb 09, 2025